ID#: 17910
This image from 2014, depicted the packaging used to contain the MedImmune, Influenza Vaccine Live, Intranasal FluMist® Quadrivalent, for the 2014-2015 flu season. FluMist® is a live attenuated influenza vaccine (LAIV), indicated for active immunization for the prevention of influenza disease, caused by two influenza-A subtype viruses, and two influenza-B type viruses contained in the vaccine, or four influenza virus strains, hence the term, quadrivalent. FluMist® is administered as a 0.2ml intranasal spray, that is introduced into the nose, 0.1ml into each nostril.
High Resolution: Click here for hi-resolution image (15.65 MB)
Content Provider(s): CDC/ Heather Richmond, MedImmune
Creation Date: 2014
Photo Credit: Kaye evens-lutterodt/PR Neswire
CDC Organization
Skip Navigation Links.

Skip Navigation Links.
Copyright Restrictions: None - This image is in the public domain and thus free of any copyright restrictions.